Burgess B Freeman (Burgess Freeman)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 14

Top Topics

Dna Damage Response

Top Venues

Nature communications

Cancer discovery

Science (New York, N.Y.)

This page only lists publications with an associated author ORCID identifier.

Publications

Camille Keenan, Sabrin Albeituni, Ninad Oak, Alexa N Stroh, Heather S Sheppard, Yingzhe Wang, Burgess B Freeman, Silvia Alemán-Arteaga, Lauren K Meyer, Rolanda Woods, Katherine C Verbist, Yinmei Zhou, Cheng Cheng, Kim E Nichols
Differential Effects of JAK1 vs. JAK2 Inhibition in Mouse Models of Hemophagocytic Lymphohistiocytosis. Blood (2024)
Noha A M Shendy, Melissa Bikowitz, Logan H Sigua, Yang Zhang, Audrey Mercier, Yousef Khashana, Stephanie Nance, Qi Liu, Ian M Delahunty, Sarah Robinson, Vanshita Goel, Matthew G Rees, Melissa A Ronan, Tingjian Wang, Mustafa Kocak, Jennifer A Roth, Yingzhe Wang, Burgess B Freeman, Brent A Orr, Brian J Abraham, Martine F Roussel, Ernst K Schonbrunn, Jun Qi, Adam D Durbin
Group 3 medulloblastoma transcriptional networks collapse under domain specific EP300/CBP inhibition. Nature communications 15 (1) (2024)
Camille Keenan, Sabrin H Albeituni, Ninad Oak, Alexa Stroh, Heather S Sheppard, Yingzhe Wang, Burgess B Freeman, Silvia Alemán-Arteaga, Lauren K Meyer, Rolanda Woods, Katherine C Verbist, Yinmei Zhou, Cheng Cheng, Kim E Nichols
Differential effects of itacitinib, fedratinib, and ruxolitinib in mouse models of hemophagocytic lymphohistiocytosis. Blood 143 (23) (2024)
Shunsuke Kimura, Chun Shik Park, Lindsey E Montefiori, Ilaria Iacobucci, Petri Polonen, Qingsong Gao, Elizabeth D Arnold, Andishe Attarbaschi, Anthony Brown, Barbara Buldini, Kenneth J Caldwell, Yunchao Chang, Chelsey Chen, Cheng Cheng, Zhongshan Cheng, John Kim Choi, Valentino Conter, Kristine R Crews, Hester A de Groot-Kruseman, Takao Deguchi, Minenori Eguchi-Ishimae, Hannah Elisa Muhle, Sarah Elitzur, Gabriele Escherich, Burgess B Freeman, Zhaohui Gu, Katie Han, Keizo Horibe, Toshihiko Imamura, Sima Jeha, Motohiro Kato, Edwynn Kean Hui Chiew, Tanya Khan, Michal Kicinski, Stefan Kohrer, Steven Mitchell Kornblau, Rishi Sury Kotecha, Chi-Kong Li, Yen-Chun Liu, Franco Locatelli, Selina M Luger, Elisabeth M Paietta, Atsushi Manabe, Hanne Vibeke Hansen Marquart, Riccardo Masetti, Mellissa Maybury, Pauline Mazilier, Jules P P Meijerink, Sharnise Mitchell, Takako Miyamura, Andrew S Moore, Koichi Oshima, Katarzyna Pawinska-Wasikowska, Rob Pieters, Mollie S Prater, Shondra M Pruett-Miller, Ching-Hong Pui, Chunxu Qu, Michaela Novakova, Noemi Reyes, Kathryn G Roberts, Jacob M Rowe, Atsushi Sato, Kjeld Schmiegelow, Martin Schrappe, Shuhong Shen, Szymon Skoczeń, Orietta Spinelli, Jan Stary, Michael Svatoň, Masatoshi Takagi, Junko Takita, Yanjing Tang, David Trent Teachey, Paul Glyndwr Thomas, Masanori Yoshida, Jan Trka, Elena Varotto, Tiffaney L Vincent, Jun J Yang, Allen Eng-Juh Yeoh, Yinmei Zhou, Martin Zimmermann, Hiroto Inaba, Charles G Mullighan
Biologic and clinical analysis of childhood gamma delta T-ALL identifies LMO2/STAG2 rearrangements as extremely high-risk. Cancer discovery (2024)
Noha A M Shendy, Melissa Bikowitz, Logan H Sigua, Yang Zhang, Audrey Mercier, Yousef Khashana, Stephanie Nance, Qi Liu, Ian M Delahunty, Sarah Robinson, Vanshita Goel, Matthew G Rees, Melissa A Ronan, Tingjian Wang, Mustafa Kocak, Jennifer A Roth, Yingzhe Wang, Burgess B Freeman, Brent A Orr, Brian J Abraham, Martine F Roussel, Ernst K Schonbrunn, Jun Qi, Adam D Durbin
Group 3 medulloblastoma transcriptional networks collapse under domain specific EP300/CBP inhibition. Nature communications 15 (1) (2024)
Noha A M Shendy, Melissa Bikowitz, Logan H Sigua, Yang Zhang, Audrey Mercier, Yousef Khashana, Stephanie Nance, Qi Liu, Ian M Delahunty, Sarah Robinson, Vanshita Goel, Matthew G Rees, Melissa A Ronan, Tingjian Wang, Mustafa Kocak, Jennifer A Roth, Yingzhe Wang, Burgess B Freeman, Brent A Orr, Brian J Abraham, Martine F Roussel, Ernst K Schonbrunn, Jun Qi, Adam D Durbin
Group 3 medulloblastoma transcriptional networks collapse under domain specific EP300/CBP inhibition. Nature communications 15 (1) (2024)
Noha A M Shendy, Melissa Bikowitz, Logan H Sigua, Yang Zhang, Audrey Mercier, Yousef Khashana, Stephanie Nance, Qi Liu, Ian M Delahunty, Sarah Robinson, Vanshita Goel, Matthew G Rees, Melissa A Ronan, Tingjian Wang, Mustafa Kocak, Jennifer A Roth, Yingzhe Wang, Burgess B Freeman, Brent A Orr, Brian J Abraham, Martine F Roussel, Ernst K Schonbrunn, Jun Qi, Adam D Durbin
Group 3 medulloblastoma transcriptional networks collapse under domain specific EP300/CBP inhibition. Nature communications 15 (1) (2024)
Shunsuke Kimura, Chun Shik Park, Lindsey E Montefiori, Ilaria Iacobucci, Petri Polonen, Qingsong Gao, Elizabeth D Arnold, Andishe Attarbaschi, Anthony Brown, Barbara Buldini, Kenneth J Caldwell, Yunchao Chang, Chelsey Chen, Cheng Cheng, Zhongshan Cheng, John Kim Choi, Valentino Conter, Kristine R Crews, Hester A de Groot-Kruseman, Takao Deguchi, Minenori Eguchi-Ishimae, Hannah Elisa Muhle, Sarah Elitzur, Gabriele Escherich, Burgess B Freeman, Zhaohui Gu, Katie Han, Keizo Horibe, Toshihiko Imamura, Sima Jeha, Motohiro Kato, Edwynn Kean Hui Chiew, Tanya Khan, Michal Kicinski, Stefan Kohrer, Steven Mitchell Kornblau, Rishi Sury Kotecha, Chi-Kong Li, Yen-Chun Liu, Franco Locatelli, Selina M Luger, Elisabeth M Paietta, Atsushi Manabe, Hanne Vibeke Hansen Marquart, Riccardo Masetti, Mellissa Maybury, Pauline Mazilier, Jules P P Meijerink, Sharnise Mitchell, Takako Miyamura, Andrew S Moore, Koichi Oshima, Katarzyna Pawinska-Wasikowska, Rob Pieters, Mollie S Prater, Shondra M Pruett-Miller, Ching-Hong Pui, Chunxu Qu, Michaela Novakova, Noemi Reyes, Kathryn G Roberts, Jacob M Rowe, Atsushi Sato, Kjeld Schmiegelow, Martin Schrappe, Shuhong Shen, Szymon Skoczeń, Orietta Spinelli, Jan Stary, Michael Svatoň, Masatoshi Takagi, Junko Takita, Yanjing Tang, David Trent Teachey, Paul Glyndwr Thomas, Masanori Yoshida, Jan Trka, Elena Varotto, Tiffaney L Vincent, Jun J Yang, Allen Eng-Juh Yeoh, Yinmei Zhou, Martin Zimmermann, Hiroto Inaba, Charles G Mullighan
Biologic and clinical analysis of childhood gamma delta T-ALL identifies LMO2/STAG2 rearrangements as extremely high-risk. Cancer discovery (2024)
Shunsuke Kimura, Chun Shik Park, Lindsey E Montefiori, Ilaria Iacobucci, Petri Polonen, Qingsong Gao, Elizabeth D Arnold, Andishe Attarbaschi, Anthony Brown, Barbara Buldini, Kenneth J Caldwell, Yunchao Chang, Chelsey Chen, Cheng Cheng, Zhongshan Cheng, John Kim Choi, Valentino Conter, Kristine R Crews, Hester A de Groot-Kruseman, Takao Deguchi, Minenori Eguchi-Ishimae, Hannah Elisa Muhle, Sarah Elitzur, Gabriele Escherich, Burgess B Freeman, Zhaohui Gu, Katie Han, Keizo Horibe, Toshihiko Imamura, Sima Jeha, Motohiro Kato, Edwynn Kean Hui Chiew, Tanya Khan, Michal Kicinski, Stefan Kohrer, Steven Mitchell Kornblau, Rishi Sury Kotecha, Chi-Kong Li, Yen-Chun Liu, Franco Locatelli, Selina M Luger, Elisabeth M Paietta, Atsushi Manabe, Hanne Vibeke Hansen Marquart, Riccardo Masetti, Mellissa Maybury, Pauline Mazilier, Jules P P Meijerink, Sharnise Mitchell, Takako Miyamura, Andrew S Moore, Koichi Oshima, Katarzyna Pawinska-Wasikowska, Rob Pieters, Mollie S Prater, Shondra M Pruett-Miller, Ching-Hong Pui, Chunxu Qu, Michaela Novakova, Noemi Reyes, Kathryn G Roberts, Jacob M Rowe, Atsushi Sato, Kjeld Schmiegelow, Martin Schrappe, Shuhong Shen, Szymon Skoczeń, Orietta Spinelli, Jan Stary, Michael Svatoň, Masatoshi Takagi, Junko Takita, Yanjing Tang, David Trent Teachey, Paul Glyndwr Thomas, Masanori Yoshida, Jan Trka, Elena Varotto, Tiffaney L Vincent, Jun J Yang, Allen Eng-Juh Yeoh, Yinmei Zhou, Martin Zimmermann, Hiroto Inaba, Charles G Mullighan
Biologic and clinical analysis of childhood gamma delta T-ALL identifies LMO2/STAG2 rearrangements as extremely high-risk. Cancer discovery (2024)
Camille Keenan, Sabrin Albeituni, Ninad Oak, Alexa N Stroh, Heather S Sheppard, Yingzhe Wang, Burgess B Freeman, Silvia Alemán-Arteaga, Lauren K Meyer, Rolanda Woods, Katherine C Verbist, Yinmei Zhou, Cheng Cheng, Kim E Nichols
Differential Effects of JAK1 vs. JAK2 Inhibition in Mouse Models of Hemophagocytic Lymphohistiocytosis. Blood (2024)
Noha A M Shendy, Melissa Bikowitz, Logan H Sigua, Yang Zhang, Audrey Mercier, Yousef Khashana, Stephanie Nance, Qi Liu, Ian M Delahunty, Sarah Robinson, Vanshita Goel, Matthew G Rees, Melissa A Ronan, Tingjian Wang, Mustafa Kocak, Jennifer A Roth, Yingzhe Wang, Burgess B Freeman, Brent A Orr, Brian J Abraham, Martine F Roussel, Ernst K Schonbrunn, Jun Qi, Adam D Durbin
Group 3 medulloblastoma transcriptional networks collapse under domain specific EP300/CBP inhibition. Nature communications 15 (1) (2024)
Martine F Roussel, Barbara Jonchere, Justin S Williams, Frederique Zindy, JingJing Liu, Sarah Robinson, Dana M Farmer, Jaeki Min, Lei Yang, Jennifer L Stripay, Yingzhe Wang, Burgess B Freeman, Jiyang Yu, Anang A Shelat, Zoran Rankovic
Combination of ribociclib with BET-bromodomain and PI3K/mTOR inhibitors for medulloblastoma treatment in vitro and in vivo. Molecular cancer therapeutics (2022)
Jay A Blundon, Noah C Roy, Brett J W Teubner, Jing Yu, Tae-Yeon Eom, K Jake Sample, Amar Pani, Richard Jay Smeyne, Seung Baek Han, Ryan A Kerekes, Derek C Rose, Troy A Hackett, Pradeep K Vuppala, Burgess B Freeman, Stanislav S Zakharenko
Restoring auditory cortex plasticity in adult mice by restricting thalamic adenosine signaling. Science (New York, N.Y.) 356 (6345) (2018)
Tal Teitz, Jie Fang, Asli N Goktug, Justine D Bonga, Shiyong Diao, Robert A Hazlitt, Luigi Iconaru, Marie Morfouace, Duane Currier, Yinmei Zhou, Robyn A Umans, Michael R Taylor, Cheng Cheng, Jaeki Min, Burgess B Freeman, Junmin Peng, Martine F Roussel, Richard Kriwacki, R Kiplin Guy, Taosheng Chen, Jian Min Zuo
CDK2 inhibitors as candidate therapeutics for cisplatin- and noise-induced hearing loss. The Journal of experimental medicine 215 (4) (2018)